0,805  0,016  Apoptosis agonist
0,703  0,008  Sensitization
0,688  0,033  Antiinflammatory
0,647  0,023  CYP3A4 substrate
0,632  0,011  Bone diseases treatment
0,627  0,009  Antiosteoporotic
0,623  0,013  CYP2C19 substrate
0,640  0,031  Caspase 9 stimulant
0,603  0,004  Antiviral (Influenza)
0,614  0,016  Carcinogenic
0,605  0,012  Immunosuppressant
0,590  0,004  Antiviral (Influenza A)
0,588  0,016  Atherosclerosis treatment
0,600  0,031  Transcription factor NF kappa B inhibitor
0,551  0,005  ICAM1 expression inhibitor
0,553  0,011  FMO1 substrate
0,530  0,005  Antiviral (Herpes)
0,555  0,031  GST A substrate
0,536  0,030  CYP2C9 substrate
0,526  0,021  CYP1A2 substrate
0,523  0,017  Lipoprotein disorders treatment
0,518  0,019  Hepatic disorders treatment
0,514  0,018  Antioxidant
0,528  0,033  Antibacterial
0,514  0,019  Antifungal
0,505  0,011  Angiogenesis stimulant
0,537  0,046  Antineoplastic (breast cancer)
0,502  0,019  Cardiovascular analeptic
0,500  0,033  Antipruritic, allergic
0,487  0,023  Antineoplastic (pancreatic cancer)
0,474  0,015  Hypolipemic
0,467  0,022  Chemopreventive
0,460  0,019  Nitric oxide antagonist
0,490  0,049  TNF expression inhibitor
0,446  0,007  Alpha-N-acetylglucosaminidase inhibitor
0,464  0,025  Antineoplastic (glioma)
0,463  0,029  Cytotoxic
0,454  0,027  Antineoplastic (brain cancer)
0,466  0,046  Antileukemic
0,448  0,029  Radioprotector
0,440  0,022  UGT2B4 substrate
0,444  0,030  Cardioprotectant
0,424  0,013  UGT1A4 substrate
0,464  0,062  Alzheimer's disease treatment
0,437  0,036  Antihypercholesterolemic
0,433  0,038  Antineoplastic (ovarian cancer)
0,437  0,044  Vasodilator, peripheral
0,406  0,014  Contraceptive
0,422  0,033  Analeptic
0,418  0,031  UGT1A9 substrate
0,405  0,024  Antiparasitic
0,394  0,013  GST M1-1 substrate
0,401  0,020  UDP-glucuronosyltransferase substrate
0,403  0,027  Antineoplastic (glioblastoma multiforme)
0,386  0,013  UGT2B7 substrate
0,400  0,038  Apoptosis antagonist
0,404  0,048  Cholesterol antagonist
0,366  0,011  Acaricide
0,378  0,025  FMO3 substrate
0,380  0,027  Myocardial infarction treatment
0,393  0,042  AR expression inhibitor
0,356  0,004  HDL-cholesterol increasing
0,371  0,020  Antihelmintic
0,390  0,042  Antineoplastic (melanoma)
0,395  0,048  Aldehyde oxidase inhibitor
0,393  0,046  Respiratory analeptic
0,382  0,035  NOS2 expression inhibitor
0,392  0,047  5 Hydroxytryptamine release stimulant
0,425  0,080  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,370  0,025  Antiulcerative
0,364  0,021  UGT1A1 substrate
0,403  0,061  CYP2C19 inhibitor
0,352  0,010  Gastrin inhibitor
0,353  0,012  Peptidyltransferase inhibitor
0,367  0,028  Vascular (periferal) disease treatment
0,369  0,034  Mutagenic
0,382  0,048  CYP2D6 substrate
0,359  0,028  DNA synthesis inhibitor
0,353  0,023  Eye irritation, high
0,343  0,015  Pneumotoxic
0,360  0,037  Proliferative diseases treatment
0,353  0,031  Antineoplastic (endocrine cancer)
0,336  0,015  Interferon gamma antagonist
0,341  0,020  Hepatoprotectant
0,393  0,082  5 Hydroxytryptamine release inhibitor
0,360  0,050  NOS3 expression inhibitor
0,327  0,018  Antiacne
0,356  0,048  CTGF expression inhibitor
0,334  0,028  Abortion inducer
0,332  0,026  RNA-directed DNA polymerase inhibitor
0,310  0,009  Antineoplastic antibiotic
0,355  0,055  Antipsoriatic
0,352  0,054  Vasodilator, coronary
0,345  0,047  Antineoplastic (cervical cancer)
0,366  0,075  Antineoplastic (lung cancer)
0,340  0,050  Interleukin 2 agonist
0,308  0,021  Antipruritic, non-allergic
0,295  0,011  UGT2B9 substrate
0,324  0,042  Flavin-containing monooxygenase substrate
0,324  0,047  Cytostatic
0,286  0,011  SULT1A3 substrate
0,352  0,077  Stroke treatment
0,308  0,034  Antiparkinsonian, rigidity relieving
0,316  0,043  Vasodilator
0,286  0,019  UGT2B15 substrate
0,273  0,007  Contraceptive female
0,328  0,066  Calcium channel activator
0,270  0,009  ATPase inhibitor
0,267  0,009  UGT2B10 substrate
0,301  0,044  5 Hydroxytryptamine uptake stimulant
0,318  0,063  Sodium/bile acid cotransporter inhibitor
0,278  0,025  Skin irritative effect
0,272  0,021  Bone formation stimulant
0,296  0,045  UGT1A6 substrate
0,264  0,016  Cholesterol synthesis inhibitor
0,271  0,025  Antihelmintic (Nematodes)
0,297  0,053  Free radical scavenger
0,346  0,102  Histamine release inhibitor
0,294  0,051  Interleukin agonist
0,243  0,004  Neuraminidase inhibitor
0,255  0,019  Acetylcholinesterase inhibitor
0,331  0,096  GABA C receptor rho-3 antagonist
0,290  0,056  Hypoglycemic
0,292  0,060  Chemoprotective
0,241  0,011  Microtubule formation inhibitor
0,286  0,058  Antineoplastic (renal cancer)
0,237  0,011  Antirickettsial
0,234  0,011  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,257  0,036  Antimutagenic
0,264  0,046  Antihypotensive
0,245  0,029  Carcinogenic, group 3
0,228  0,013  Arachidonic acid antagonist
0,217  0,004  Neuraminidase (influenza) inhibitor
0,298  0,086  Prostate cancer treatment
0,279  0,068  Teratogen
0,310  0,102  Ulceration
0,213  0,007  Estrogen agonist
0,214  0,009  Adenylate cyclase stimulant
0,241  0,036  Antiviral (Hepatitis)
0,241  0,037  Lipocortins synthesis antagonist
0,217  0,016  UDP-glucose 4-epimerase inhibitor
0,266  0,065  Antineoplastic (liver cancer)
0,243  0,042  Neurotrophic factor enhancer
0,269  0,069  Antineoplastic (non-small cell lung cancer)
0,221  0,025  Antifungal enhancer
0,262  0,069  Embryotoxic
0,216  0,023  Glutathione S-transferase substrate
0,243  0,051  VCAM1 expression inhibitor
0,275  0,084  Antiepileptic
0,204  0,013  Androgen antagonist
0,207  0,017  SULT1A1 substrate
0,223  0,033  Melanin inhibitor
0,193  0,003  ATPase (Vacuolar H+) inhibitor
0,269  0,082  Antihypoxic
0,235  0,050  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,190  0,005  Transcription factor AP-1 inhibitor
0,189  0,004  Bcl2 antagonist
0,187  0,005  Ca2+-transporting ATPase inhibitor
0,204  0,022  Ferrochelatase inhibitor
0,218  0,039  Cholinergic
0,186  0,009  Postmenopausal disorders treatment
0,249  0,073  Acute neurologic disorders treatment
0,201  0,027  GST P1-1 substrate
0,208  0,035  Skin whitener
0,180  0,007  Anabolic
0,207  0,038  Antiviral (Hepatitis C)
0,242  0,076  Tyrosine 3 hydroxylase inhibitor
0,233  0,067  Antimitotic
0,222  0,057  Nitric-oxide synthase stimulant
0,171  0,008  UGT2B11 substrate
0,204  0,045  Succinate dehydrogenase inhibitor
0,195  0,037  Genotoxic
0,204  0,048  UGT1A3 substrate
0,223  0,069  Psychostimulant
0,258  0,105  Caspase 3 stimulant
0,173  0,021  Antiviral (CMV)
0,190  0,040  Carcinogenic, group 1
0,175  0,026  GABA C receptor agonist
0,167  0,019  Antiviral (Influenza B)
0,165  0,016  Triose-phosphate isomerase inhibitor
0,171  0,024  Choleretic
0,195  0,048  Phospholipase C inhibitor
0,245  0,099  Antineoplastic (multiple myeloma)
0,305  0,159  Cyclophilin D inhibitor
0,305  0,159  Antidiabetic
0,158  0,014  GST T1-1 substrate
0,212  0,068  Anesthetic general
0,190  0,045  Protein kinase stimulant
0,172  0,029  Antiviral (Poxvirus)
0,156  0,013  Keratolytic
0,178  0,036  DNA polymerase I inhibitor
0,157  0,016  NADH dehydrogenase inhibitor
0,175  0,035  Antiviral (Hepatitis B)
0,160  0,020  Antispirochetal
0,185  0,047  Antineoplastic (squamous cell carcinoma)
0,236  0,097  Spasmolytic
0,155  0,018  Toll-Like receptor 4 antagonist
0,141  0,005  Antimycoplasmal
0,137  0,001  Progesterone receptor B antagonist
0,159  0,023  Adenylate kinase inhibitor
0,175  0,041  CF transmembrane conductance regulator agonist
0,152  0,020  Actinic keratosis treatment
0,167  0,035  Antihemorrhagic
0,168  0,036  Farnesoid X receptor antagonist
0,164  0,032  Growth stimulant
0,151  0,021  Neutropenia treatment
0,153  0,023  Creatine kinase inhibitor
0,221  0,092  Tumour necrosis factor alpha release inhibitor
0,154  0,026  Sulfotransferase substrate
0,178  0,051  Lipid peroxidase inhibitor
0,257  0,130  Antineoplastic (small cell lung cancer)
0,144  0,018  Inducible nitric-oxide synthase inhibitor
0,179  0,053  Uterine stimulant
0,144  0,019  Phosphofructokinase-1 inhibitor
0,141  0,017  Antidote, mercury
0,135  0,012  Alcohol oxidase inhibitor
0,220  0,098  Superoxide dismutase inhibitor
0,203  0,082  Antihypertriglyceridemic
0,146  0,027  Dementia treatment
0,130  0,012  Biliverdin reductase inhibitor
0,121  0,004  Neuraminidase (Influenza A) inhibitor
0,128  0,010  Glycine receptor agonist
0,151  0,035  Expectorant
0,223  0,108  Immunostimulant
0,137  0,022  Antibiotic
0,151  0,037  Vanilloid 1 agonist
0,141  0,027  Vascular dementia treatment
0,147  0,033  TRPA1 agonist
0,133  0,020  Tourette's syndrome treatment
0,125  0,013  T cell inhibitor
0,117  0,005  Bcl-xL inhibitor
0,116  0,004  Postcoital contraceptive
0,143  0,032  UGT2B1 substrate
0,155  0,045  Retinoprotector
0,125  0,016  Glycine receptor antagonist
0,191  0,083  Insulin sensitizer
0,153  0,046  Antihyperlipoproteinemic
0,111  0,005  SULT2A1 substrate
0,115  0,011  Androgen agonist
0,179  0,075  Diabetic retinopathy treatment
0,164  0,060  Heat shock protein 90 antagonist
0,195  0,093  Cardiodepressant
0,142  0,041  Excitatory amino acid transporter EAAC1 inhibitor
0,126  0,025  Lanosterol 14 alpha demethylase inhibitor
0,125  0,027  Antithrombocytopenic
0,210  0,111  Antineoplastic (sarcoma)
0,151  0,053  Antiseptic
0,160  0,063  Hair growth stimulant
0,171  0,073  Phobic disorders treatment
0,107  0,011  Protein 50S ribosomal subunit inhibitor
0,202  0,106  Antipyretic
0,115  0,020  Na+ K+ transporting ATPase inhibitor
0,170  0,075  Muscle relaxant
0,123  0,029  Acetylcholine nicotinic antagonist
0,174  0,080  LDLR expression enhancer
0,156  0,061  Antiprotozoal (Coccidial)
0,111  0,017  SULT1A2 substrate
0,190  0,096  Antialcoholic
0,156  0,063  Antiparkinsonian, tremor relieving
0,119  0,026  Ornithine decarboxylase inhibitor
0,097  0,005  Adenylate cyclase 1 inhibitor
0,215  0,123  Antineoplastic (colorectal cancer)
0,104  0,012  Antidote, organophosphates
0,098  0,008  Heme oxygenase stimulant
0,208  0,118  Antineoplastic (colon cancer)
0,108  0,018  Carbamoyl phosphate synthetase inhibitor
0,104  0,015  Acyl-CoA dehydrogenase inhibitor
0,122  0,033  Carcinogenic, group 2A
0,146  0,059  Pregnane X receptor agonist
0,166  0,080  Toxic, respiratory center
0,138  0,052  Monophenol monooxygenase inhibitor
0,136  0,050  Antineoplastic antimetabolite
0,140  0,055  Antismoking
0,176  0,090  CYP2B6 inhibitor
0,113  0,029  Transcription factor NF kappa B stimulant
0,188  0,104  Antineoplastic (lymphoma)
0,126  0,044  AMP-activated protein kinase stimulant
0,116  0,034  Thioredoxin inhibitor
0,154  0,072  Cytidine deaminase inhibitor
0,089  0,007  Anesthetic inhalation
0,124  0,042  Antineoplastic, alkylator
0,129  0,047  Photosensitizer
0,099  0,018  Anticholelithogenic
0,145  0,064  Anesthetic
0,224  0,143  CYP3A4 inhibitor
0,152  0,071  Hearing loss treatment
0,158  0,078  Prostate disorders treatment
0,095  0,015  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,126  0,047  GABA C receptor antagonist
0,101  0,024  Estrogen-related receptor beta agonist
0,096  0,020  Vanilloid 4 agonist
0,124  0,048  Estrogen antagonist
0,184  0,107  Cyclic AMP phosphodiesterase inhibitor
0,112  0,036  SULT1E1 substrate
0,127  0,053  Cystathionine beta-synthase inhibitor
0,103  0,029  Glutamate dehydrogenase inhibitor
0,150  0,078  Peroxidase inhibitor
0,143  0,071  Antifungal (Cryptococcus)
0,077  0,005  Retinoic acid alpha receptor agonist
0,104  0,033  Contraceptive male
0,088  0,017  Glutamate (mGluR6) antagonist
0,076  0,005  Microtubule stabilization
0,140  0,069  Amylase inhibitor
0,079  0,009  Glucose-6-phosphate isomerase inhibitor
0,212  0,143  Nootropic
0,221  0,152  Antithrombotic
0,096  0,028  Narcotic antagonist
0,195  0,127  Antiviral (West Nile virus)
0,077  0,008  Pregnane X receptor antagonist
0,124  0,056  Antifungal (Pneumocystis)
0,149  0,082  Neuropathy treatment
0,089  0,022  Argininosuccinate synthase inhibitor
0,177  0,112  Antineoplastic enhancer
0,078  0,013  5-Alpha-reductase inhibitor
0,095  0,031  GABA aminotransferase inhibitor
0,119  0,055  Mucolytic
0,207  0,144  Hypoxia-inducible factor 1 alpha inhibitor
0,127  0,064  Coagulant
0,077  0,014  Antiviral (Herpesvirus 3, Human)
0,078  0,017  Calcium channel P-type blocker
0,069  0,009  Glucocorticoid antagonist
0,114  0,054  Antiprotozoal (Toxoplasma)
0,064  0,004  Cholesterol ester transfer protein antagonist
0,062  0,005  Tubulin agonist
0,146  0,090  Growth hormone agonist
0,107  0,050  Nitric-oxide synthase inhibitor
0,135  0,079  Mannose-6-phosphate isomerase inhibitor
0,064  0,008  Guanylate cyclase inhibitor
0,094  0,039  Porphobilinogen synthase inhibitor
0,113  0,058  Carcinogenic, group 2B
0,067  0,013  Progesterone antagonist
0,079  0,025  Purinergic P2X1 antagonist
0,070  0,017  Alpha-mannosidase inhibitor
0,158  0,105  P-glycoprotein inhibitor
0,090  0,039  Antiviral (Dengue virus)
0,119  0,068  Adenylate cyclase inhibitor
0,076  0,026  Antiviral (Parainfluenza)
0,105  0,055  Estrogen receptor beta antagonist
0,093  0,043  Vanilloid agonist
0,110  0,062  Antihelmintic (Fasciola)
0,069  0,022  Lipocortins synthesis agonist
0,232  0,185  CYP2C9 inhibitor
0,108  0,062  DOPA decarboxylase inhibitor
0,052  0,006  HMG CoA reductase inhibitor
0,098  0,053  Bile acid receptor antagonist
0,121  0,076  Cyclooxygenase 3 inhibitor
0,077  0,032  Gaucher disease treatment
0,073  0,028  Hypercalcemia treatment
0,059  0,014  Thymidine kinase inhibitor
0,068  0,023  Sphingosine kinase 2 inhibitor
0,127  0,084  Psychosexual dysfunction treatment
0,116  0,073  Alcohol dehydrogenase substrate
0,187  0,144  Amyotrophic lateral sclerosis treatment
0,166  0,124  VEGF expression inhibitor
0,066  0,024  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,136  0,094  Raynaud's phenomenon treatment
0,068  0,028  Sphingosine kinase inhibitor
0,083  0,044  Estrogen receptor alpha antagonist
0,081  0,041  Aminopeptidase I inhibitor
0,093  0,054  Glutamate release inhibitor
0,126  0,087  CC chemokine 6 receptor antagonist
0,137  0,098  Aldose reductase substrate
0,135  0,097  Heat shock protein 70 antagonist
0,098  0,061  Electrolyte absorption antagonist
0,056  0,020  Mannosidase inhibitor
0,047  0,011  Vanilloid 3 antagonist
0,040  0,004  Vanilloid 2 agonist
0,188  0,153  Antiischemic
0,101  0,068  Beta glucuronidase inhibitor
0,055  0,023  Cholesterol esterase inhibitor
0,048  0,016  Kainate receptor agonist
0,112  0,080  Aldehyde dehydrogenase inhibitor
0,087  0,056  Sodium/hydrogen exchanger 5 inhibitor
0,112  0,081  Cholinergic antagonist
0,048  0,018  Estrogen receptor alpha agonist
0,036  0,006  Thymidine kinase (Herpes simplex virus 1) inhibitor
0,045  0,015  Delayed rectifier potassium channel blocker
0,069  0,040  MDM2 inhibitor
0,114  0,085  Sphingosine 1-phosphate receptor 4 antagonist
0,060  0,031  Glucosylceramidase inhibitor
0,123  0,095  Cell wall synthesis inhibitor
0,057  0,030  Nicotinic alpha3beta2 receptor antagonist
0,184  0,157  Radiosensitizer
0,042  0,016  RNA-directed RNA polymerase stimulant
0,029  0,003  Telomerase stimulant
0,078  0,053  MAP kinase kinase 7 inhibitor
0,042  0,017  Fumarate hydratase inhibitor
0,053  0,029  Squalene epoxidase inhibitor
0,111  0,087  Cathepsin H inhibitor
0,106  0,082  Alkylator
0,055  0,031  Aconitate hydratase inhibitor
0,029  0,005  Thymidine kinase (Herpes simplex virus 2) inhibitor
0,030  0,006  Retinoic acid alpha receptor antagonist
0,045  0,022  Sphingosine kinase 1 inhibitor
0,032  0,009  Hedgehog signaling activator
0,029  0,006  Retinoic acid beta receptor agonist
0,088  0,066  Paget's disease treatment
0,138  0,116  Sedative
0,140  0,119  Aldehyde oxidase substrate
0,093  0,072  GABA C receptor rho-1 antagonist
0,099  0,079  Antihypermotility
0,073  0,052  S-adenosyl-L-methionine decarboxylase inhibitor
0,030  0,010  Retinoic acid receptor agonist
0,041  0,022  Retinoid X receptor antagonist
0,028  0,009  GRP78 expression inhibitor
0,032  0,013  Purinergic P2Y15 antagonist
0,040  0,021  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,026  0,007  Retinoic acid receptor antagonist
0,023  0,006  Antibiotic Anthracycline-like
0,097  0,081  Protein-tyrosine phosphatase 1B inhibitor
0,036  0,020  Retinoid X alpha receptor antagonist
0,058  0,043  Heat shock protein 90 beta antagonist
0,154  0,140  Antineoplastic (lymphocytic leukemia)
0,035  0,021  Sodium-dependent vitamin C transporter 2 inhibitor
0,157  0,143  Antiviral (HIV)
0,047  0,033  Potassium channel Kv1.3 blocker
0,041  0,028  Cholesterol absorption inhibitor
0,027  0,014  Sodium/glucose cotransporter 1 inhibitor
0,033  0,020  ATP citrate lysase inhibitor
0,058  0,045  Ryanodine receptor antagonist
0,146  0,134  Anticonvulsant
0,121  0,109  Insulin secretagoues
0,219  0,207  Alpha-glucosidase inhibitor
0,045  0,033  Phosphorylase inhibitor
0,045  0,033  Parathyroid hormone antagonist
0,027  0,016  Sodium/glucose cotransporter inhibitor
0,038  0,027  Glutamate (mGluR8) agonist
0,061  0,051  Interferon inducer
0,032  0,022  Glutamate (mGluR3) agonist
0,078  0,068  NMDA receptor antagonist
0,038  0,029  Membrane dipeptidase inhibitor
0,112  0,103  Antineoplastic (carcinoma)
0,017  0,009  Thromboxane A2 agonist
0,013  0,005  Progesterone receptor A antagonist
0,019  0,011  Methylmalonyl-CoA mutase inhibitor
0,067  0,059  Glutamate decarboxylase inhibitor
0,063  0,056  Premenstrual syndrome treatment
0,021  0,014  Retinoid X beta receptor antagonist
0,038  0,031  Dopamine D5 agonist
0,139  0,132  Non-steroidal antiinflammatory agent
0,100  0,093  Acetylcholine antagonist
0,040  0,034  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,033  0,027  Retinoid X alpha receptor agonist
0,026  0,021  Uridine phosphorylase inhibitor
0,025  0,020  Sodium/glucose cotransporter 2 inhibitor
0,104  0,099  Toll-Like receptor 2 antagonist
0,015  0,009  Antibiotic Macrolide-like
0,022  0,017  Retinoid X gamma receptor agonist
0,019  0,014  Vesicular acetylcholine transporter inhibitor
0,011  0,007  Thromboxane agonist
0,089  0,085  Antifungal (Candida)
0,123  0,119  GABA C receptor rho-2 antagonist
0,041  0,038  Heme oxygenase inhibitor
0,046  0,043  Ornithine carbamoyltransferase inhibitor
0,016  0,014  Progesterone agonist
0,021  0,018  Prostaglandin F2 alpha agonist
0,016  0,013  Vitamin D receptor agonist
0,021  0,018  Retinoic acid gamma receptor agonist
0,040  0,037  Geranyltranstransferase inhibitor
0,080  0,078  Tocolytic
0,129  0,128  Movement disorders treatment
0,071  0,069  Interferon agonist
0,059  0,059  Uterine relaxant
0,085  0,085  Chronic obstructive bronchitis treatment
0,024  0,023  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,025  0,025  Retinoid X gamma receptor antagonist
0,046  0,045  Potassium channel (Inward rectifier) activator
0,081  0,080  Prolactin inhibitor
0,005  0,005  Transcortin receptor antagonist

